ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Minority Health"

  • Abstract Number: 0005 • ACR Convergence 2022

    The Rheumatology Access Expansion (RAE) Initiative: Improving Rheumatoid Arthritis Care on Navajo Nation Through Primary Care Provider Education

    Jennifer Mandal1, Tabitha Carroway2, Zara Izadi1, Gwendolyn Grant3, Mary Margaretten2, Starla Blanks4, Nataya Cabrera4, Peter Emanuel2, Jeannie Hong5, Sheryl McCalla4, John McDougall6, Catherine Nasrallah7, McKinsey Pillsbury2 and Jinoos Yazdany2, 1University of California San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3Centura Health, Durango, CO, 4American College of Rheumatology, Atlanta, GA, 5Phoenix Indian Medical Center/Indian Health Service, Phoenix, AZ, 6Northern Navajo Medical Center - Shiprock, NM, Shiprock, NM, 7UCSF, San Francisco

    Background/Purpose: The burden of rheumatoid arthritis (RA) in the United States falls disproportionately on communities of color and rural populations. The Navajo Nation is the…
  • Abstract Number: 2162 • ACR Convergence 2022

    Systemic Sclerosis in Alaska Native/American Indian People in Alaska

    Vivek Mehta and Elizabeth Ferucci, Alaska Native Tribal Health Consortium, Anchorage, AK

    Background/Purpose: Systemic sclerosis (SSc) is known to have more severe manifestations and higher mortality in Black populations, while fewer studies have examined disparities in epidemiology…
  • Abstract Number: 0115 • ACR Convergence 2022

    Facilitators of Immunosuppressive Medication Adherence in Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers and Clinic Staff

    Shannon Herndon1, Amy Corneli2, Carrie Dombeck3, Teresa Swezey3, Megan Clowse3, Jennifer Rogers4, Lisa Criscione-Schreiber2, Rebecca Sadun3, Jayanth Doss3, Amanda Eudy5, Hayden Bosworth2 and Kai Sun3, 1Duke University Hospital, Durham, NC, 2Duke University School of Medicine, Durham, NC, 3Duke University, Durham, NC, 4Duke, Durham, NC, 5Duke University, Raleigh, NC

    Background/Purpose: SLE disproportionately affects patients of color. Medication nonadherence is more common among patients of color with SLE and is associated with worse health outcomes.…
  • Abstract Number: 0116 • ACR Convergence 2022

    Racial Differences in Medication Beliefs and Barriers to Taking Medications Among Patients with SLE

    Emilio Guzman Cisneros1, Shannon Herndon1, Theresa Coles2, Corrine Voils3, Megan Clowse4, Rebecca Sadun4, Jennifer Rogers5, Lisa Criscione-Schreiber2, Jayanth Doss4, Amanda Eudy6 and Kai Sun4, 1Duke University Hospital, Durham, NC, 2Duke University School of Medicine, Durham, NC, 3University of Wisconsin School of Medicine and Public Health, Madison, WI, 4Duke University, Durham, NC, 5Duke, Durham, NC, 6Duke University, Raleigh, NC

    Background/Purpose: Medication adherence is critical for SLE management and can be influenced by patients' barriers and beliefs about treatment. Patients of color with SLE have…
  • Abstract Number: 0120 • ACR Convergence 2022

    Epstein Barr Virus Reactivation in Native American Rheumatic Disease Patients Is Associated with Systemic Disease and Rheumatoid Arthritis but Not Other Rheumatic Diseases

    Carla J. Guthridge1, Catriona Wagner2, Sohail Khan3, Michael Peercy4, Bobby Saunkeah4, Joel Guthridge1 and Judith James1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Santa Cruz, CA, 3Cherokee Nation, Tahlequah, OK, 4Chickasaw Nation, Ada, OK

    Background/Purpose: EBV infection is associated with autoantibody development in the preclinical period of rheumatic diseases, such as SLE and RA. Furthermore, EBV reactivation, characterized by…
  • Abstract Number: 0181 • ACR Convergence 2022

    Patient Perspective of Unique Support and Education Needs of Latinx/Latino(a)/Hispanic Rheumatoid Arthritis Patients: Implications for a Culturally Tailored and Disease Specific Intervention

    Anna Balakrishnan1, Adena Batterman1, Daniel Hernandez2, Angel Tapia3, Joan Westreich1, Roberta Horton1 and Theodore Fields1, 1Hospital for Special Surgery, New York, NY, 2Global Healthy Living Foundation, Nyack, NY, 3Global Healthy Living Foundation, Upper Nyack, NY

    Background/Purpose: Health disparities for Latinx RA patients, including higher pain, fatigue, disability, and risk for depression are well documented.1, 2, 3, 4 Support and education…
  • Abstract Number: 0188 • ACR Convergence 2022

    COVID-19 and Autoimmune Rheumatic Patients: Behavioral Changes Adopted by Patients in the Midst of the Pandemic

    Dzifa Dey1, Bright Katso2, Saudatu Issaka2, Derrick Nyame3 and Patrick Adjei1, 1University of Ghana Medical School, Accra, Ghana, 2Rheumatology Unit Korle bu Teaching Hospital, Accra, Ghana, 3Korle bu Teaching Hospital, Accra, Ghana

    Background/Purpose: Several changes following the COVID-19 pandemic have emerged globally regarding the delivery of healthcare services. Giving concerns that, patients with Autoimmune Rheumatic Disease (AIRD)…
  • Abstract Number: 0631 • ACR Convergence 2022

    Perfluoroalkyl Substances and Community Vulnerability: Associations with Lupus-Related Autoantibodies and Disease

    Emily Vara, Dulaney Wilson, John Pearce, Jim Oates and Diane Kamen, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Perfluoroalkyl substances (PFAS) are a class of persistent organic pollutants found in nonstick products, water repellant fabrics, fire-retardant foams, and food packaging. Highly stable,…
  • Abstract Number: 0349 • ACR Convergence 2021

    Performance of the 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus in a Predominantly African American Cohort

    Jessica English1, Dulaney Wilson2, Gary Gilkeson2, Jim Oates2 and Diane Kamen2, 1Medical University of South Carolina, Johns Island, SC, 2Medical University of South Carolina, Charleston, SC

    Background/Purpose: Classification criteria for systemic lupus erythematosus (SLE) were recently published by the European League Against Rheumatism (EULAR) and American College of Rheumatology (ACR) to…
  • Abstract Number: 0350 • ACR Convergence 2021

    EPI-SIGN: Epigenetic SLE Indicators of Glomerular Nephritis

    Ashira Blazer1, Olusola Ayanlowo2, Will Liao3, Dzifa Dey4, Jasmin Divers5, Uyiekpen Ima-Edomwonyin6, Hakeem Olaosebikan7, Cristina Lanata8, Girish Nadkarni9, Jill Buyon1, Peter Izmirly10 and Timothy Niewold11, 1NYU School of Medicine, New York, NY, 2College of Medicine University of Lagos, New York, NY, 3New York Genome Center, New York, NY, 4University of Ghana, Accra, Ghana, 5NYU Langone Hospital - Long Island, Mineola, NY, 6Lagos State University Teaching Hospital, Lagos, Nigeria, 7Lagos University State Teaching Hospital, Lagos, Nigeria, 8University of California San Francisco, Moss Beach, CA, 9Icahn School of Medicine at Mount Sinai, New York, NY, 10New York University School of Medicine, New York, NY, 11Colton Center for Autoimmunity NYU School of Medicine, New York, NY

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is more common and severe in those of African Ancestry (AA) who, relative to Europeans, are twice as likely to…
  • Abstract Number: 0601 • ACR Convergence 2021

    Racial Differences in Medication Beliefs Among SLE Patients

    D Ryan Anderson1, Amanda Eudy2, Megan Clowse3, Rebecca Sadun2, Jennifer Rogers2, Lisa Criscione-Schreiber4, Jayanth Doss2, Corrine Volis5, Theresa Coles2 and Kai Sun2, 1Duke University Hospital, Durham, NC, 2Duke University, Durham, NC, 3Duke University, Chapel Hill, NC, 4Duke University School of Medicine, Durham, NC, 5University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Medication adherence is essential to establishing and maintaining disease remission among SLE patients. Patients’ beliefs about treatment influence engagement and adherence to therapy. We…
  • Abstract Number: 0616 • ACR Convergence 2021

    Race and Socioeconomic Status and COVID-19 Outcomes in Patients with Rheumatic Diseases: Findings from a Tertiary Care Center in the Deep South

    Adam Taylor, Dongmei Sun, Jeffrey Foster and Maria I. Danila, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: The southern United States is home to a large proportion of non-Hispanic Black Americans, a group which has historically been disproportionately affected by healthcare…
  • Abstract Number: 0622 • ACR Convergence 2021

    Ethnic Disparities in Giant-Cell Arteritis: A Clinical Comparison Among Caucasian and Hispanic Patients in the Inland Empire of Southern California

    Kathleena D'Anna and Mehrnaz Hojjati, Loma Linda University Health, Loma Linda, CA

    Background/Purpose: Giant-Cell Arteritis (GCA) is the most common systemic vasculitis among North Americans, historically described in Caucasian populations, with limited clinical data in other ethnic…
  • Abstract Number: 0632 • ACR Convergence 2021

    Impact of COVID-19 and Telehealth on RAPID3 Screening in an Academic Rheumatology Practice: Identifying Disparities in Care

    Poorva Apte1, Robert Overton2, Ricardo Henao1, Nicoleta Economou-Zavlanos2, Jayanth Doss1, Megan Clowse3 and David Leverenz1, 1Duke University, Durham, NC, 2Duke Clinical Research Institute, Durham, NC, 3Duke University, Chapel Hill, NC

    Background/Purpose: Measuring disease activity in patients with inflammatory arthritis is important for providing optimal treat-to-target care. The COVID-19 pandemic has widened disparities in care among…
  • Abstract Number: 1151 • ACR Convergence 2021

    Experiences and Finding Meaning Among Latin Americans Living with Lupus: Learning from Social Media Narratives by Patients and Their Social Network

    Tirsa Colmenares-Roa1, Alfonso Gastelum-Strozzi2, Erica Crosley3, Yurilis Fuentes-Silva4, Cristina Reategui-Sokolova5, Claudia Elera-Fitzcarrald6, Soledad Ibañez7, Ernesto Cairoli8, Bernardo A. Pons-Estel9, Ingris Peláez-Ballestas1 and Cristina Drenkard10, 1Hospital General de Mexico "Dr. Eduardo Liceaga", Mexico, Mexico, 2Instituto de Ciencias Aplicadas y Tecnología, Universidad Nacional Autónoma de México, Mexico, Mexico, 3John Hopkins University, Baltimore, MD, 4Division of Rheumatology, Complejo Hospitalario Universitario Ruiz y Páez, Universidad de Oriente, Ciudad Bolívar, Centro Nacional de Enfermedades Reumáticas, Ciudad Bolívar, Venezuela, 5Hospital Guillermo Almenara Irigoyen, Lima, Peru, 6Universidad Cientifica del Sur/Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, 7Sanatorio Güemes, Buenos Aires, Argentina, 8Autoimmune Diseases Unit, Centro Asistencial del Sindicato Médico del Uruguay (CASMU) and Hospital Evangélico, Montevideo, Uruguay, 9Grupo Oroo - Centro Regional de Enfermedades Autoinmunes y Reumticas (GO-CREAR), Rosario, Argentina, 10Emory University, Atlanta, GA

    Background/Purpose: SLE disproportionately affects Latin Americans, and outcomes are worse amongst them compared to non-minority populations. Understanding patients' views of living with SLE is critical…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology